Benefits
May Shorten the Common Cold (Cold Lozenges)
Zinc acetate lozenges are among the best-studied cold lozenges and may help shorten a cold when started at the first sign of symptoms. The authoritative 2024 Cochrane review, however, rated the evidence low to very-low certainty with inconsistent benefits, so any effect is unproven and appears to depend on formulation and ionic-zinc dose. Some earlier Hemila analyses suggested zinc acetate might release more zinc ions at saliva pH than gluconate.
Wilson's Disease: Prescription Drug Use (Informational — Not a Supplement Claim)
This is a prescription medical use, not a dietary-supplement benefit. Zinc acetate (Galzin®) is FDA-approved for Wilson's disease — a genetic disorder of copper metabolism causing copper accumulation in liver, brain, and other organs. High-dose zinc acetate (50 mg elemental zinc TID) induces metallothionein in intestinal cells, sequestering dietary copper and preventing absorption. Prescription only; requires hepatology supervision.
Bioavailability
Zinc acetate is well-absorbed — among the well-bioavailable forms. Releases zinc ions readily at saliva and gastric pH.
Standard Zinc Benefits
Same general zinc benefits as other forms — immune support, skin/wound healing, growth/development, taste/smell, antioxidant function.
Reasonable Cost
Zinc acetate is cost-comparable to gluconate; a reasonable choice for both supplementation and lozenge applications.
Mechanism of action
Zinc Ion Release at Throat pH
Hemilä's research suggests zinc acetate releases more zinc ions in saliva than zinc gluconate — a proposed basis for a possible, modest cold-shortening advantage. The clinically relevant variable is total Zn²⁺ concentration in throat mucosa during lozenge dissolution.
Wilson's Disease Mechanism (Metallothionein Induction)
High-dose oral zinc acetate induces metallothionein in enterocytes — a small protein that binds and sequesters copper. Dietary copper binds metallothionein, fails to absorb, and is shed with intestinal epithelial cells into stool. Effective copper elimination strategy.
Acetic Acid Release
Acetic acid (vinegar) is well-tolerated and rapidly metabolized to acetyl-CoA — innocuous at supplemental amounts.
Standard Zinc Enzyme Functions
Same as other zinc forms — >300 enzyme cofactor, zinc finger transcription factors, antioxidant via Cu/Zn-SOD.
Clinical trials
Subgroup comparisons within Hemila pooled meta-analyses of zinc acetate vs zinc gluconate lozenges for cold duration (distinct from the 2024 Cochrane review).
Pooled across cold lozenge clinical trials.
Earlier pooled analyses suggested both forms may shorten colds, with zinc acetate possibly having a modest edge over gluconate. The 2024 Cochrane review, however, rated the overall evidence low to very-low certainty with inconsistent benefits, so these figures should be read cautiously rather than as established effects.
Prescription medical use under hepatology supervision, not a dietary-supplement benefit. Trials of zinc acetate (50 mg elemental zinc TID) in Wilson's disease patients for maintenance therapy after initial chelation.
Wilson's disease patients.
Zinc acetate effectively maintains negative copper balance in Wilson's disease — induces intestinal metallothionein blocking copper absorption. FDA-approved (Galzin®) for Wilson's. Prescription pharmaceutical use.